TMA-TNP Design
Heidi S Feiler, Koei Chin
tissue microarray
TMA
breast cancer
spatial analysis
data integration
biospecimen
FFPE
spatial mapping
OMS Atlas
HTAN
Abstract
Human Tumor Atlas Tissue MicroArrary TNP (TMA-TNP)
The Tissue MicroArray (TMA) TNP will extend the SARDANA-TNP characterization and analytics methodologies for evaluation and validation on a large array of breast tumor samples that provide a broad spectrum of disease state and subtype. A commercially available anonymized breast tumor TMA was purchased and sections distributed to participating HTAN Centers. Some deidentified basic clinical data will also be provided. The participating HTAN Centers will characterize the FFPE specimens (e.g. by imaging) and generate a spatially resolved cell type/state census using each Center’s method of choice. Data will then be recorded in a common repository to enable joint analysis.
This TNP has two specific Aims focused on (i) Data Collection and (ii) Data Coordination and Analysis. Individual Centers can participate in one or both aims.
This protocol outlines the design of the TMAs and provides the basic clinical sample descriptions.
Steps
TMA Map of Participant IDs
A custom breast TMA design generated by Dr. Koei Chin (OHSU) was sent to Pantomics for TMA FFPE block generation and sectioning. The randomized array design, outlined below, was used to generate 2 identical TMAs, TMA1 and TMA2. Cores from tumor samples with Pantomics Ref. No. were arrayed as shown (the matching HTAN Participant IDs are also shown).
A | B | C |
---|---|---|
Array Position | Pantomics Ref. No. | HTAN Participant ID |
A01 | F11-0369 | HTA14_1 |
A02 | F08-3884 | HTA14_2 |
A03 | F11-0957 | HTA14_3 |
A04 | F08-0824 | HTA14_4 |
A05 | F18-0992 | HTA14_5 |
A06 | 255287-OHSU | HTA14_6 |
A07 | F13-1953 | HTA14_7 |
A08 | F11-3564 | HTA14_8 |
A09 | 316473-OHSU | HTA14_9 |
A10 | F10-1047 | HTA14_10 |
A11 | MCF10A-KC | HTA14_11 |
B01 | F16-0582 | HTA14_12 |
B02 | HCC1143 | HTA14_13 |
B03 | F08-1273 | HTA14_14 |
B04 | F17-3395A3 | HTA14_15 |
B05 | F10-0051 | HTA14_16 |
B06 | F10-0992 | HTA14_17 |
B07 | F09-1280 | HTA14_18 |
B08 | HCC3153 | HTA14_19 |
B09 | F16-0582 | HTA14_12 |
B10 | F09-0328 | HTA14_20 |
B11 | MDAMB436-KC | HTA14_21 |
C01 | F09-3051 | HTA14_22 |
C02 | F13-0368 | HTA14_23 |
C03 | F10-0572 | HTA14_24 |
C04 | F09-1290 | HTA14_25 |
C05 | F11-3564 | HTA14_8 |
C06 | 316473-OHSU | HTA14_9 |
C07 | F09-4287 | HTA14_26 |
C08 | F10-0572 | HTA14_24 |
C09 | F10-4365 | HTA14_27 |
C10 | F08-1426 | HTA14_28 |
C11 | HCC1143-KC | HTA14_29 |
D01 | 255287-OHSU | HTA14_6 |
D02 | F16-2497 | HTA14_30 |
D03 | F09-2873 | HTA14_31 |
D04 | F10-0587 | HTA14_32 |
D05 | T47D | HTA14_33 |
D06 | F09-0328 | HTA14_20 |
D07 | F09-1814 | HTA14_34 |
D08 | 232527-OHSU | HTA14_35 |
D09 | AU565 | HTA14_36 |
D10 | F08-3884 | HTA14_2 |
D11 | HCC3153-KC | HTA14_37 |
E01 | F15-0002 | HTA14_38 |
E02 | F08-0824 | HTA14_4 |
E03 | 326007-OHSU | HTA14_39 |
E04 | F18-0992 | HTA14_5 |
E05 | F10-1015 | HTA14_40 |
E06 | F11-0957 | HTA14_3 |
E07 | F08-1273 | HTA14_14 |
E08 | F09-3051 | HTA14_22 |
E09 | F10-0587 | HTA14_32 |
E10 | F08-0773 | HTA14_41 |
E11 | AU565-KC | HTA14_42 |
F01 | F10-4365 | HTA14_27 |
F02 | F09-4287 | HTA14_26 |
F03 | F13-1953 | HTA14_7 |
F04 | F09-3432 | HTA14_43 |
F05 | F10-0342 | HTA14_44 |
F06 | F15-0002A1 | HTA14_38 |
F07 | F16-2497 | HTA14_30 |
F08 | F10-1047 | HTA14_10 |
F09 | F11-1210 | HTA14_45 |
F10 | F09-2873 | HTA14_31 |
F11 | BT474-KC | HTA14_46 |
G01 | F10-1015 | HTA14_40 |
G02 | F09-1814 | HTA14_34 |
G03 | F11-1210 | HTA14_45 |
G04 | 232527-OHSU | HTA14_35 |
G05 | F11-0369 | HTA14_1 |
G06 | F08-0773 | HTA14_41 |
G07 | F13-0368 | HTA14_23 |
G08 | 326007-OHSU | HTA14_39 |
G09 | F10-0992 | HTA14_17 |
G10 | F09-1290 | HTA14_25 |
G11 | T47D-KC | HTA14_47 |
H01 | BT474 | HTA14_48 |
H02 | F09-3034 | HTA14_49 |
H03 | F09-1280 | HTA14_18 |
H04 | F08-1426 | HTA14_28 |
H05 | MDAMB436 | HTA14_50 |
H06 | F10-0051 | HTA14_16 |
H07 | F09-3432 | HTA14_43 |
H08 | F09-3034 | HTA14_49 |
H09 | F17-3395 | HTA14_15 |
H10 | F10-0342 | HTA14_44 |
H11 | MCF10A | HTA14_51 |
TMA Clinical Sample Descriptions
A | B | C | D | E | F | G | H |
---|---|---|---|---|---|---|---|
HTAN Participant ID | Age | Sex | Anat. Site | Pathology | Grade | Clinic stage (TNM) | Subtybe |
HTA14_25 | 43 | F | Breast | Invasive ductal carcinoma | I | T2N2M0 | Luminal A |
HTA14_34 | 55 | F | Breast | Invasive ductal carcinoma | II | T2N2M0 | Luminal A |
HTA14_5 | 43 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | Luminal A |
HTA14_10 | 48 | F | Breast | Invasive ductal carcinoma | I | T1N1M0 | Luminal A |
HTA14_1 | 56 | F | Breast | Invasive ductal carcinoma | II | T2N2M0 | Luminal A |
HTA14_14 | 44 | F | Breast | Invasive ductal carcinoma | II | T2N1M0 | Luminal B Her2+ |
HTA14_28 | 37 | F | Breast | Invasive ductal carcinoma | II | T4N0M0 | Luminal B Her2+ |
HTA14_26 | 47 | F | Breast | Invasive ductal carcinoma | II | T2N1M0 | Luminal B Her2+ |
HTA14_44 | 69 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | Luminal B Her2+ |
HTA14_32 | 49 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | Luminal B Her2+ |
HTA14_41 | 37 | F | Breast | Invasive ductal carcinoma | III | T1N0M0 | Luminal B HER- |
HTA14_4 | 43 | F | Breast | Invasive ductal carcinoma | II | T1N0M0 | Luminal B HER- |
HTA14_24 | 59 | F | Breast | Invasive lobular carcinoma | II | T2N0M0 | Luminal B HER- |
HTA14_17 | 43 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | Luminal B HER- |
HTA14_40 | 69 | F | Breast | Invasive ductal carcinoma | II | T2N1M0 | Luminal B HER- |
HTA14_20 | 65 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | Her2 over-expression |
HTA14_18 | 42 | F | Breast | Invasive ductal carcinoma | III | T2N0M0 | Her2 over-expression |
HTA14_31 | 52 | F | Breast | Invasive ductal carcinoma | I | T2N2M0 | Her2 over-expression |
HTA14_22 | 50 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | Her2 over-expression |
HTA14_43 | 40 | F | Breast | Invasive ductal carcinoma | III | T2N0M0 | Her2 over-expression |
HTA14_27 | 32 | F | Breast | Invasive ductal carcinoma | III | T3N0M0 | TNBC |
HTA14_3 | 76 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | TNBC |
HTA14_45 | 51 | F | Breast | Invasive ductal carcinoma | III | T2N0M0 | TNBC |
HTA14_8 | 39 | F | Breast | Invasive ductal carcinoma | II | T2N0M0 | TNBC |
HTA14_23 | 30 | F | Breast | Invasive ductal carcinoma | III | T3N2M0 | TNBC |
HTA14_49 | 67 | F | Breast | Invasive lobular carcinoma | II | T3N1M0 | Invasive lobular carcinoma |
HTA14_16 | 55 | F | Breast | Invasive lobular carcinoma | II | T4N3M0 | Invasive lobular carcinoma |
HTA14_7 | 42 | F | Breast | Invasive lobular carcinoma | II | T2N3M0 | Invasive lobular carcinoma |
HTA14_12 | 38 | F | Breast | Invasive lobular carcinoma | II | T2N0M0 | Invasive lobular carcinoma |
HTA14_30 | 49 | F | Breast | Invasive lobular carcinoma | I | T3N2M0 | Invasive lobular carcinoma |
HTA14_38 | 5 | M | Tonsil | Normal Tonsil | Normal Tonsil | ||
HTA14_15 | 68 | M | Jejunum | Normal Jejunum | Normal Jejunum | ||
HTA14_13 | Breast cell line | HCC1143 | Basal Like | ||||
HTA14_19 | Breast cell line | HCC3153 | Basal Like | ||||
HTA14_33 | Breast cell line | T47D | Luminal A | ||||
HTA14_48 | Breast cell line | BT474 | Luminal B | ||||
HTA14_36 | Breast cell line | AU565 | Her2 over-expression | ||||
HTA14_50 | Breast cell line | MDAMB436 | Claudin Low | ||||
HTA14_51 | Breast cell line | MCF10A | Cystic fibrosis | ||||
HTA14_2 | 43 | F | Normal Breast | Normal Breast to IDC | NB-1A | ||
HTA14_35 | Normal Breast | Normal Adacent Tissue | NB-2A | ||||
HTA14_6 | Normal Breast | Normal Adacent Tissue | NB-3A | ||||
HTA14_39 | Normal Breast | True Normal | NB-4A | ||||
HTA14_9 | Normal Breast | True Normal | NB-5B | ||||
HTA14_47 | Breast cell line | HCC1143 | Luminal A | ||||
HTA14_46 | Breast cell line | HCC3153 | Luminal B | ||||
HTA14_42 | Breast cell line | T47D | HER2 | ||||
HTA14_37 | Breast cell line | BT474 | Basal Like | ||||
HTA14_29 | Breast cell line | AU565 | Basal Like | ||||
HTA14_21 | Breast cell line | MDAMB436 | Claudin Low | ||||
HTA14_11 | Breast cell line | MCF10A | Cystic fibrosis |